Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Esomeprazole	107
Overall Study	STARTED	Ranitidine	112
Overall Study	Number of Patients Received Treatment	Esomeprazole	107
Overall Study	Number of Patients Received Treatment	Ranitidine	111
Overall Study	Patients Included in ITT Population	Esomeprazole	106
Overall Study	Patients Included in ITT Population	Ranitidine	111
Overall Study	Patients Included in Safety Population	Esomeprazole	107
Overall Study	Patients Included in Safety Population	Ranitidine	110
Overall Study	Patients Included in Per-Protocol Popula	Esomeprazole	100
Overall Study	Patients Included in Per-Protocol Popula	Ranitidine	99
Overall Study	COMPLETED	Esomeprazole	97
Overall Study	COMPLETED	Ranitidine	94
Overall Study	NOT COMPLETED	Esomeprazole	10
Overall Study	NOT COMPLETED	Ranitidine	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00401752/flow